The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Smoke signals – do they help to predict TAVI-associated stroke risk?

EuroIntervention 2021;16:1046-1047. DOI: 10.4244/EIJV16I13A191

1. Oxford University NHS Trust and Oxford NIHR Biomedical Research Centre, Oxford, United Kingdom

Disabling stroke is the complication patients fear most when discussing treatment of severe aortic stenosis. The reported incidence of stroke following transcatheter aortic valve implantation (TAVI) varies from 1 to 9%: the PARTNER 3 trial demonstrated a 30-day stroke rate of 0.6% in low-risk patients, and the SENTINEL trial demonstrated a 9% stroke rate in the control group of patients1,2. As the threshold for considering TAVI moves into a younger and lower-risk population, the impact of disabling stroke on morbidity, mortality and healthcare costs becomes even more relevant.

Patient and procedural factors contribute to the risk of stroke early after TAVI and include ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group